Apollo Hospitals is currently trading at Rs. 667.35, up by 1.90 points or 0.29% from its previous closing of Rs. 665.45 on the BSE.
The scrip opened at Rs. 673.00 and has touched a high and low of Rs. 674.90 and Rs. 667.00 respectively. So far 1278 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 716.90 on 05-Dec-2011 and a 52 week low of Rs. 432.30 on 24-Jun-2011.
Last one week high and low of the scrip stood at Rs. 697.75 and Rs. 633.00 respectively. The current market cap of the company is Rs. 9004.56 crore.
The promoters holding in the company stood at 33.10% while Institutions and Non-Institutions held 42.44% and 20.48% respectively.
Apollo Hospitals, in bid for a deeper penetration is planning to add another 2,955 beds across the country. The company will add it in the next three years entailing an investment of Rs 1,940 crore. With the addition of 2,955 beds, the total bed strength of the healthcare chain would go up to around 8,800 beds by 2014-15.
Besides, the healthcare major is also planning to add another 14 hospital under its chain of hospitals. This addition will take the total number of hospitals from 37 to 51 by 2014-15.
Apollo Hospitals, is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8834.00 |
| Max Healthcare Inst. | 1119.80 |
| Narayana Hrudayalay. | 2000.75 |
| Aster DM Quality | 789.35 |
| Global Health | 1324.30 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: